Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic lewy body disease

John Anderson, Donald Walker, Jason Goldstein, Rian de Laat, Kelly Banducci, Russell Caccavello, Robin Barbour, Jiping Huang, Kristin Kling, Michael Lee, Linnea Diep, Pamela Keim, Xiaofeng Shen, Timothy Chataway, Michael Schlossmacher, Peter Seubert, Dale Schenk, Sukanto Sinha, Weiping Gai, Tamie Chilcote

    Research output: Contribution to journalArticle

    676 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)29739-29752
    Number of pages14
    JournalJournal of Biological Chemistry
    Volume281
    Issue number40
    Publication statusPublished - 2006

    Cite this

    Anderson, J., Walker, D., Goldstein, J., de Laat, R., Banducci, K., Caccavello, R., Barbour, R., Huang, J., Kling, K., Lee, M., Diep, L., Keim, P., Shen, X., Chataway, T., Schlossmacher, M., Seubert, P., Schenk, D., Sinha, S., Gai, W., & Chilcote, T. (2006). Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic lewy body disease. Journal of Biological Chemistry, 281(40), 29739-29752.